Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data
- PMID: 34020816
- PMCID: PMC8186488
- DOI: 10.1016/j.vaccine.2021.04.047
Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data
Abstract
Background: Coverage rates for immunization have dropped in lower income countries during the COVID-19 pandemic, raising concerns regarding potential outbreaks and premature death. In order to re-invigorate immunization service delivery, sufficient financing must be made available from all sources, and particularly from government resources. This study utilizes the most recent data available to provide an updated comparison of available data sources on government spending on immunization.
Methods: We examined data from WHO/UNICEF's Joint Reporting Form (JRF), country Comprehensive Multi-Year Plan (cMYP), country co-financing data for Gavi, and WHO National Health Accounts (NHA) on government spending on immunization for consistency by comparing routine and vaccine spending where both values were reported. We also examined spending trends across time, quantified underreporting and utilized concordance analyses to assess the magnitude of difference between the data sources.
Results: Routine immunization spending reported through the cMYP was nearly double that reported through the JRF (rho = 0.64, 95% 0.53 to 0.77) and almost four times higher than that reported through the NHA on average (rho = 3.71, 95% 1.00 to 13.87). Routine immunization spending from the JRF was comparable to spending reported in the NHA (rho = 1.30, 95% 0.97 to 1.75) and vaccine spending from the JRF was comparable to that from the cMYP data (rho = 0.97, 95% 0.84 to 1.12). Vaccine spending from both the JRF and cMYP was higher than Gavi co-financing by a at least two (rho = 2.66, 95% 2.45 to 2.89) and (rho = 2.66, 95% 2.15 to 3.30), respectively.
Implications: Overall, our comparative analysis provides a degree of confidence in the validity of existing reporting mechanisms for immunization spending while highlighting areas for potential improvements. Users of these data sources should factor these into consideration when utilizing the data. Additionally, partners should work with governments to encourage more reliable, comprehensive, and accurate reporting of vaccine and immunization spending.
Keywords: Government spending; Immunization spending; Joint Reporting Form; National Health Accounts.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




References
-
- WHO | Global Vaccine Action Plan 2011-2020. World Health Organization. https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_201... (accessed Sept 30, 2020).
-
- WHO | Global Vaccine Action Plan. https://www.who.int/teams/immunization-vaccines-and-biologicals/strategi... (accessed March 31, 2021).
-
- Gavi’s Co-financing policy. Gavi. https://www.gavi.org/programmes-impact/programmatic-policies/co-financin... (accessed Sept 30, 2020).
-
- WHO | WHO/UNICEF Joint Reporting Process. World Health Organization. http://www.who.int/immunization/monitoring_surveillance/routine/reportin... (accessed Sept 30, 2020).
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical